Skip to content
Medical InsightsKoreaMedical Insights Korea

Gallbladder

Does having my gallbladder removed increase my risk of cancer?

Korean national data covering 715,872 operations shows a raised cancer rate afterwards. The shape of that rise over time is the part that answers the question.

Answer

Korean national cohorts do find more hepato-biliary-pancreatic cancer diagnosed after gallbladder removal — an incidence rate ratio of 1.08 across 715,872 patients against 1,431,728 matched controls — but the excess is concentrated in the first one to three years after surgery and returns to the level of matched controls after five to ten years, which is the pattern expected when the cancer was already present rather than caused by the operation.

Key takeaways

  • In a Korean National Health Insurance Service cohort of 715,872 people who had a cholecystectomy and 1,431,728 matched controls, the incidence rate ratio for gastrointestinal and hepato-biliary-pancreatic cancers was 1.08 (95 percent confidence interval 1.06 to 1.10).
  • The excess was highest one to three years after surgery and had returned to the level of matched controls by five to ten years.
  • The raised rates were largest for extrahepatic bile duct cancer (rate ratio 1.92) and intrahepatic bile duct cancer (1.78), and smaller for hepatocellular carcinoma (1.22) and pancreatic cancer (1.13).
  • A rise that appears immediately after an operation and then disappears is the signature of disease that was already there being found, not of the operation causing new disease years later.
  • Separate Korean cohorts also report higher rates of type 2 diabetes and chronic kidney disease after cholecystectomy, and a raised risk of depression within three years but not beyond.

This question gets asked because the headline finding is real and alarming, and because the studies reporting it are large enough that they are hard to dismiss. The answer is in the timing rather than the size of the effect.

What the Korean data shows

A population study using Korea's National Health Insurance Service compared 715,872 people who had their gallbladder removed against 1,431,728 matched people who did not.

Rate ratios for cancer after cholecystectomy, Korean national cohort
CancerRate ratio
All GI and hepato-biliary-pancreatic1.08
Extrahepatic bile duct1.92
Intrahepatic bile duct1.78
Hepatocellular carcinoma1.22
Pancreatic1.13

Taken alone those numbers read as an operation that causes cancer. Then the study reports when the excess occurred.

1–3 years

when the excess cancer diagnoses were concentrated; by 5 to 10 years the rate had returned to that of matched controls

Why the timing settles it

Cancers caused by something take years to appear and the excess keeps growing, because each year adds more people whose disease has had time to develop. That is the shape seen with smoking and lung cancer.

The shape here is the opposite. The excess is largest immediately, then shrinks, then vanishes. That is what happens when disease that was already present gets found earlier than it otherwise would have been.

This is called detection bias, and it is the reason a study cannot be read from its rate ratios alone. The same study that produces the alarming number also produces the evidence against reading it that way.

What else Korean data reports

  • Type 2 diabetes: roughly 20 percent higher in a cohort of 55,166 patients.
  • Chronic kidney disease: roughly 21 percent higher in a separate national cohort.
  • Depression: raised within three years of surgery (adjusted hazard ratio 1.38, 1.19 to 1.59) but not beyond three years (1.09, 0.98 to 1.22), with no association with suicide in any period.

These carry the same difficulty in a different form. People who need a gallbladder removed are not a random sample of the population — gallstones share risk factors with diabetes and metabolic disease, so the people who have the operation were already at higher risk of what follows it. Matching corrects only for what was recorded.

What would change this answer

  1. All of these are observational. Nobody randomises people to lose a gallbladder, so causation cannot be established from any of them.
  2. The reassurance rests on the excess disappearing by five to ten years. A study with longer follow-up finding it re-emerging would change the conclusion, and none has.
  3. Detection bias explains the timing well and is not the only possible explanation. Bile acid physiology does change after the gallbladder is removed, and that hypothesis is not disproved by these data.
  4. The diabetes and kidney findings have not been shown to follow the same time course as the cancer finding, so the same reasoning cannot simply be transferred to them.
  5. None of this bears on whether an individual should have the operation. That decision rests on what the gallbladder is doing now, which this publication covers separately.

The defensible summary is that more cancer is diagnosed after gallbladder removal, that this is concentrated in the years immediately after surgery and then disappears, and that the most economical explanation is earlier detection of disease that was already there rather than an operation that causes cancer.

Sources

  1. Kim YA, Kim HJ, Kang MJ, Han SS, Park HM, Park SJ

    Increased diagnosis of hepato-biliary-pancreatic cancer after cholecystectomy: a population-based study
  2. Choi YJ, Jin EH, Lim JH, Shin CM, Kim N, Han K, Lee DH

    Increased Risk of Cancer after Cholecystectomy: A Nationwide Cohort Study in Korea including 123,295 Patients
  3. Huh JH, Lee KJ, Cho YK, Moon S, Kim YJ, Roh E, et al.

    Cholecystectomy Increases the Risk of Type 2 Diabetes in the Korean Population: Data From the National Health Insurance Cooperation Health Checkup 2010-2017
  4. Heo JH, Kim EJ, Jung HN, Han KD, Kang JG, Lee SJ, et al.

    Cholecystectomy Increases the Risk of Chronic Kidney Disease: A Nationwide Longitudinal Cohort Study
  5. Yu J, Park S, Jeong S, Ko A, Lee J, Han S, Park SM

    Association of cholecystectomy with short-term and long-term risks of depression and suicide